ReviewFrontiers in pharmacology2020

A Comprehensive Review of Clinical Cardiotoxicity Incidence of FDA-Approved Small-Molecule Kinase Inhibitors.

Ying Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.